Importance of allogeneic stem cell transplantation in myelofibrosis

  • Allogeneic stem cell transplantation (alloSCT) is the only curative treatment option for patients with high-risk myelofibrosis (MF). However, it is important to bear in mind that alloSCT in MF is associated with a nonrelapse mortality that should not be underestimated. Therefore, both exact disease risk categorization and thorough evaluation of the individual transplant-related risk are mandatory to identify those patients to whom alloSCT should be offered. This short review is intended to provide a concise overview on relevant aspects to be considered for patient selection, planning, and performing alloSCT.

Download full text files

Export metadata

Statistics

Number of document requests

Additional Services

Share in Twitter Search Google Scholar
Metadaten
Author:Klaus HirschbühlORCiD, Christoph Schmid
URN:urn:nbn:de:bvb:384-opus4-1158986
Frontdoor URLhttps://opus.bibliothek.uni-augsburg.de/opus4/115898
ISSN:1865-5041OPAC
ISSN:1865-5076OPAC
Parent Title (English):memo - Magazine of European Medical Oncology
Publisher:Springer
Place of publication:Berlin
Type:Article
Language:English
Year of first Publication:2024
Publishing Institution:Universität Augsburg
Release Date:2024/10/17
Volume:17
Issue:3
First Page:215
Last Page:219
DOI:https://doi.org/10.1007/s12254-024-00987-5
Institutes:Medizinische Fakultät
Medizinische Fakultät / Universitätsklinikum
Medizinische Fakultät / Lehrstuhl für Innere Medizin mit Schwerpunkt Hämatologie und Onkologie
Medizinische Fakultät / Professur für Transplantation und Zelltherapieforschung
Dewey Decimal Classification:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Licence (German):License LogoCC-BY 4.0: Creative Commons: Namensnennung (mit Print on Demand)